Attendees will gain practical insight into how AI is being incorporated into biomarker-led development strategies across the clinical lifecycle. An interactive closing discussion will consider where AI can have the greatest impact on trial design and execution, as well as the challenges involved in turning increasingly complex biomarker datasets into actionable clinical evidence.  

• Improve Patient Stratification – Explore how AI can identify biomarker-defined populations and support more targeted trial design
• Turn Complex Data Into Decisions – Discover approaches for integrating multimodal biomarker data and generating predictive insights
• Accelerate Clinical Development – Learn how AI-enabled biomarker strategies can support trial enrichment, response prediction and more efficient decision-making

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.